SC
PFE icon

Stance Capital’s Pfizer PFE Stock Holding History

Stance Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
+78,762
New +$2.06M 0.58% 58
2026
Q1 		– Sell
-26,846
Closed -$668K – 308
2025
Q4 		$668K Buy
26,846
+26,746
+26,746% +$674K 0.25% 130
2025
Q3 		$2.55K Buy
+100
New +$2.47K ﹤0.01% 269
2025
Q1 		– Sell
-7,257
Closed -$193K – 215
2024
Q4 		$193K Buy
+7,257
New +$197K 0.12% 60

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stance Capital's PFE Position: Q2 2026 in Review

Stance Capital opened a new position in Pfizer (PFE) in Q2 2026: 78,762 shares worth $1.9M. The stake represents 0.58% of the portfolio and ranks #58 among its holdings. This is a return to the name: Stance Capital previously reported a position in PFE as recently as Q4 2025.

Stance Capital first reported a position in PFE in Q4 2024 and has held it in 4 quarters since. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stance Capital held 78,762 shares of Pfizer worth $1.9M as of Q2 2026.
  • Pfizer was a new Stance Capital position in Q2 2026.
  • Pfizer made up 0.58% of Stance Capital's portfolio in Q2 2026, its #58 holding.
  • Stance Capital first reported a position in Pfizer in Q4 2024 and has held it in 4 quarters since.
  • 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.